期刊文献+

泛靶点的抗艾滋病病毒药物高通量筛选系统

原文传递
导出
摘要 获得性免疫缺陷综合征(acquired immune deficiency syndrome,AIDS)即艾滋病,是由艾滋病病毒(human immunodeficiency virus,HIV)引起的一种人类免疫系统疾病.从1983年,法国科学家宣布第一次从艾滋病病人体内分离出艾滋病病毒[1]至今,已经过去26年了,虽然生物学家和医学家们一直都在和艾滋病病毒进行着不懈地斗争,但是时值今日,艾滋病依然是人类无法战胜的疾病之一.
出处 《科学通报》 EI CAS CSCD 北大核心 2009年第24期3920-3921,共2页 Chinese Science Bulletin
  • 相关文献

参考文献9

  • 1Barre-Sinoussi F, Chermann J C, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 1983, 220:868-871.
  • 2Shafer R W, Schapiro J M. HIV-1 drug resistance mutations: An updated framework for the second decade of HAART. AIDS Rev, 2008, 10:67-84.
  • 3Sung H, Jung Y S, Kang M W, et al. High frequency of drug resistance mutations in human immunodeficiency virus type 1-infected Korean patients treated with HAART. AIDS Res Human Retrovir, 2007, 23:1223-1229.
  • 4Wang Y M, Dyer W B, Workman C, et al. Drug resistance and viral evolution in plasma and peripheral blood cells during structured treatment interruption (ST1) and non-interrupted HAART. Curt HIV Res, 2007, 5:235-250.
  • 5Hogg R S, Bangsberg D R, Lima V D, et al. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Med, 2006, 3:e356.
  • 6Chew C B, Potter S J, Wang B, et al. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J Clin Virol, 2005, 33:206-216.
  • 7Potter S J, Dwyer D E, Saksena N K. Differential cellular distribution of HIV-1 drug resistance in vivo: Evidence for infection of CD8^+ T cells during HAART. Virology, 2003, 305:339-352.
  • 8Roge B T, Katzenstein T L, Nielsen H L, et al. Drug resistance mutations and outcome of second-line treatment in patients with first-line protease inhibitor failure on nelfinavir-containing HAART. HIV Med, 2003, 4:38-47.
  • 9Cao J, Isaacson J, Patick A K, et al. High-throughput human immunodcficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral target. Antimicrob Agents Chemother, 2005, 49:3833-3841.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部